Synthomer plc (LON:SYNT - Get Free Report) shares passed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 193.43 ($2.45) and traded as high as GBX 274.50 ($3.47). Synthomer shares last traded at GBX 266 ($3.37), with a volume of 440,881 shares changing hands.
Analysts Set New Price Targets
Separately, Berenberg Bank reaffirmed a "buy" rating and issued a GBX 320 ($4.05) price target on shares of Synthomer in a research note on Wednesday, March 13th. Two research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of GBX 224.40 ($2.84).
Read Our Latest Research Report on SYNT
Synthomer Stock Up 3.3 %
The company has a quick ratio of 0.97, a current ratio of 1.95 and a debt-to-equity ratio of 79.72. The company has a market capitalization of £435.10 million, a price-to-earnings ratio of -221.67, a P/E/G ratio of -0.17 and a beta of 1.78. The stock's fifty day moving average price is GBX 192.85 and its 200-day moving average price is GBX 189.24.
Synthomer Company Profile
(
Get Free Report)
Synthomer plc operates as a specialty chemicals company in the United Kingdom and internationally. It operates through five segments: Performance Elastomers, Functional Solutions, Industrial Specialities, Acrylate Monomers, and Adhesive Technologies. The company offers adhesives, including PSA labels, packaging and specialty tapes, saturants, release coatings, wood working, wet glues, hygiene and contact adhesives, packaging and assembly hot melt adhesives; coatings products such as architectural, masonry, intumescent, metal, wood, soil releases, blinders, ink receptive, polyester for powder coatings, SYNTHOMER NX for coalescing agents, and SYNOLOX BEPF for glycol.
Featured Stories
Before you consider Synthomer, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synthomer wasn't on the list.
While Synthomer currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
